Facing a Shift in Paradigm at the Bedside?
- 1 Department of Internal Medicine, Hospital Universitario de Mostoles, Madrid, Spain
- 2 Department of Internal Medicine, Hospital Universitario de Mostoles, Madrid, Spain
Abstract
Our entire medical framework is based on the concept of disease, understood as a qualitative departure from normality (health) with a structural substrate (lesion), and usually an identifiable cause (aetiology). This paradigm is loaded with problems, some of which are discussed in the text. Nevertheless, we study, diagnose and treat diseases, and while often painfully conscious of the dysfunctionalities of this scheme, we can hardly imagine how we could practice medicine otherwise. However, most of the recent developments in basic sciences, and most notably in Immunology, Genetics and - omics, are inconsistent with this “health/disease” paradigm. The emerging scenario is that of complex networks, more in the spirit of Systems Biology. In these settings the qualitative difference between health and disease loses its mean ing, and the whole discourse becomes progressively irreducible to our conventional clinical categories. As clinical re search stagnates while basic sciences thrive, this gap is widening, and a change in the prevailing paradigm seems un avoidable. However, all our clinical judgments (including Bayesian reasoning and Evidence Based Medicine) are rooted in the disease/health dichotomy, and one can hardly conceive how they could work without it. The shift in paradigm will not be easy, and certain turmoil is to be expected.
- T. S. Kuhn and I. Hacking, “The Structure of Scientific Revolutions,” 50th Anniversary Edition, University of Chicago Press, Chicago, 2012.
- P. Lain Entralgo, “El Diagnóstico Médico. Historia Y teoría,” Salvat Editores SA, Barcelona, 1982.
- M. Foucault, “Naissance de la Clinique: Archéologie du Regard Médical,” Presses Universitaires de France, Paris, 1972.
- P. Nash, P. J. Mease, J. Braun and D. van der Heijde, “Seronegative Spondyloarthropathies: To Lump or Split?” Annals of the Rheumatic Diseases, Vol. 64, No. Supplement 2, 2005, pp. ii9-ii13. doi:10.1136/ard.2004.033654
- A. M. Silverstein, “A History of Immunology,” Academic Press, Waltham, 1989.
- E. S. Lander, L. M. Linton, B. Birren, et al., “Initial Sequencing and Analysis of the Human Genome,” Nature, Vol. 409, No. 6822, 2001, pp. 860-921. doi:10.1038/35057062
- B. R. Graveley, “Alternative Splicing: Increasing Diversity in the Proteomic World,” Trends in Genetics, Vol. 17, No. 2, 2001, pp. 100-107. doi:10.1016/S0168-9525(00)02176-4
- S. C. Parker, L. Hansen, H. O. Abaan, T. D. Tullius and E. H. Margulies, “Local DNA Topography Correlates with Functional Noncoding Regions of the Human Genome,” Science, Vol. 324, No. 5925, 2009, pp. 389-392. doi:10.1126/science.1169050
- M. Bizzarri, A. Giuliani, A. Cucina, F. D’Anselmi, A. M. Soto and C. Sonnenschein, “Fractal Analysis in a Systems Biology Approach to Cancer,” Seminars in Cancer Biology, Vol. 21, No. 3, pp. 175-182.
- S. Dinicola, F. D’Anselmi, A. Pasqualato, et al., “A Systems Biology Approach to Cancer: Fractals, Attractors, and Nonlinear Dynamics,” Omics, Vol. 15, No. 3, pp. 93-104. doi:10.1089/omi.2010.0091
- “Omes and Omics,” 2013. http://omics.org/index.php/Omes_and_Omics
- J. Quackenbush, “Microarray Analysis and Tumor Classification,” The New England Journal of Medicine, Vol. 354, No. 23, 2006, pp. 2463-2472. doi:10.1056/NEJMra042342
- C. M. Perou, T. Sorlie, M. B. Eisen, et al., “Molecular Portraits of Human Breast Tumours,” Nature, Vol. 406, No. 6797, 2000, pp. 747-752. doi:10.1038/35021093
- L. J. van’t Veer, H. Dai, M. J. van de Vijver, et al., “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer,” Nature, Vol. 415, No. 6871, 2002, pp. 530-536. doi:10.1038/415530a
- A. A. Alizadeh, M. B. Eisen, R. E. Davis, et al., “Distinct Types of Diffuse Large B-Cell Lymphoma Identified by Gene Expression Profiling,” Nature, Vol. 403, No. 6769, 2000, pp. 503-511. doi:10.1038/35000501